Trial Profile
A phase I/IIa trial to investigate hyaluronic acid-doxorubicin in patients with metastatic cancers
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 12 Jan 2016
Price :
$35
*
At a glance
- Drugs Doxorubicin (Primary)
- Indications Cancer
- Focus Adverse reactions; Therapeutic Use
- 12 Jan 2016 Results published on the Alchemia website.
- 12 Jan 2016 New trial record